These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5068940)

  • 1. Use of cannulated everted intestinal sac for serial sampling as a drug absorbability (permeability) screen.
    Kaplan SA; Cotler S
    J Pharm Sci; 1972 Sep; 61(9):1361-5. PubMed ID: 5068940
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates.
    Doluisio JT; Billups NF; Dittert LW; Sugita ET; Swintosky JV
    J Pharm Sci; 1969 Oct; 58(10):1196-200. PubMed ID: 5394662
    [No Abstract]   [Full Text] [Related]  

  • 3. Striving Towards the Perfect In Vitro Oral Drug Absorption Model.
    Gleeson JP; McCartney F
    Trends Pharmacol Sci; 2019 Oct; 40(10):720-724. PubMed ID: 31422894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everted rat intestinal sacs as an in vitro model for assessing absorptivity of new drugs.
    Chowhan ZT; Amaro AA
    J Pharm Sci; 1977 Sep; 66(9):1249-53. PubMed ID: 20492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral absorption enhancement: taking the next steps in therapeutic delivery.
    Brayden DJ; Maher S
    Ther Deliv; 2010 Jul; 1(1):5-9. PubMed ID: 22816114
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug transport. V. Mechanism of potassium-ion inhibition of passive transfer of solutes across everted rat intestine.
    Mayersohn M; Gibaldi M; Grundhofer B
    J Pharm Sci; 1971 Dec; 60(12):1813-7. PubMed ID: 5157995
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
    Pade D; Jamei M; Rostami-Hodjegan A; Turner DB
    Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
    Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
    Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.
    Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G
    Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
    Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
    Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption.
    Annaert P; Brouwers J; Bijnens A; Lammert F; Tack J; Augustijns P
    Eur J Pharm Sci; 2010 Jan; 39(1-3):15-22. PubMed ID: 19837159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans.
    Lennernäs H; Nylander S; Ungell AL
    Pharm Res; 1997 May; 14(5):667-71. PubMed ID: 9165541
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug transfer across intact rat intestinal mucosa following surgical removal of serosa and muscularis externa.
    Wolfe DL; Forland SC; Benet LZ
    J Pharm Sci; 1973 Feb; 62(2):200-5. PubMed ID: 4686389
    [No Abstract]   [Full Text] [Related]  

  • 14. The complex task of measuring intestinal permeability in basic and clinical science.
    Galipeau HJ; Verdu EF
    Neurogastroenterol Motil; 2016 Jul; 28(7):957-65. PubMed ID: 27339216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of in vivo absorption of drug complexes.
    Feldman S; Richardson J; Freeman C; Pollock S; Berger J; Kaplan F; Rhoa G
    J Pharm Sci; 1974 Mar; 63(3):454-6. PubMed ID: 4820385
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
    Mudra DR; Borchardt RT
    J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of surfactant effects on drug absorption.
    Gibaldi M; Feldman S
    J Pharm Sci; 1970 May; 59(5):579-89. PubMed ID: 4911055
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model.
    Ruan LP; Chen S; Yu BY; Zhu DN; Cordell GA; Qiu SX
    Eur J Med Chem; 2006 May; 41(5):605-10. PubMed ID: 16546303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.